Actuate Therapeutics Files 2024 10-K

Ticker: ACTU · Form: 10-K · Filed: Mar 13, 2025 · CIK: 1652935

Actuate Therapeutics, Inc. 10-K Filing Summary
FieldDetail
CompanyActuate Therapeutics, Inc. (ACTU)
Form Type10-K
Filed DateMar 13, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, pharmaceuticals, annual-report

TL;DR

Actuate Therapeutics filed its 2024 10-K, detailing its financial status and business operations.

AI Summary

Actuate Therapeutics, Inc. filed its 2024 10-K on March 13, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as Apotheca Therapeutics, Inc. until September 11, 2015, is incorporated in Delaware and operates in the pharmaceutical preparations sector. Its principal business address is in Fort Worth, Texas.

Why It Matters

This filing provides a comprehensive overview of Actuate Therapeutics' financial performance and business operations for the fiscal year 2024, crucial for investors and stakeholders to assess the company's health and future prospects.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Actuate Therapeutics is subject to significant regulatory, research and development, and market risks inherent in the industry.

Key Numbers

  • 2024 — Fiscal Year (Reporting period for the 10-K filing.)
  • 2023 — Prior Fiscal Year (For comparative financial analysis.)

Key Players & Entities

  • ACTUATE THERAPEUTICS, INC. (company) — Filer
  • Apotheca Therapeutics, Inc. (company) — Former Company Name
  • 2024-12-31 (date) — Fiscal Year End
  • 2025-03-13 (date) — Filing Date
  • Fort Worth, TX (location) — Business Address

FAQ

What is the primary business of Actuate Therapeutics, Inc.?

Actuate Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.

When was Actuate Therapeutics, Inc. formerly known as Apotheca Therapeutics, Inc.?

The company changed its name from Apotheca Therapeutics, Inc. on September 11, 2015.

What is the filing date of this 10-K report?

This 10-K report was filed on March 13, 2025.

What is the fiscal year end for Actuate Therapeutics, Inc.?

The fiscal year end for Actuate Therapeutics, Inc. is December 31.

Where is Actuate Therapeutics, Inc. located?

The company's business and mailing address is 1751 River Run, Suite 400, Fort Worth, TX 76107.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 13, 2025 regarding ACTUATE THERAPEUTICS, INC. (ACTU).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.